MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP26F6405 to DMS Pharmaceutical Group Inc on June 6, 2026. This award is a delivery order issued under the primary contract SPE2DX25D9900 for the procurement of Meloxicam tablets, identified by national stock number 6505015413243. The contract was managed by the Department of Defense and posted via the DIBBS system. While the total contract price is specified within the award documentation, the agreement focuses on the supply of pharmaceutical goods to support federal agency requirements.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
3AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
